
Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism
Keywords: ریواروکسابان; Pulmonary embolism; Rivaroxaban; CYP2C9; VKORC1; Deep venous thrombosis;